JenniferLynn(Reifel)MalinMD
Oncology • Los Angeles, CAAssociate Professor, Medicine, UCLA School of Medicine
Dr. Malin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11301 Wilshire Blvd
West Los Angeles Healthcare Center
Los Angeles, CA 90073Phone+1 310-478-3711
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1999- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1992 - 1995
David Geffen School of Medicine at UCLAClass of 1992
Certifications & Licensure
MI State Medical License 2023 - 2026
TX State Medical License 2023 - 2026
AR State Medical License 2024 - 2025
CA State Medical License 1993 - 2025
KY State Medical License 2024 - 2025
LA State Medical License 2023 - 2025
MN State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsIs race/ethnicity related to the presence or severity of pain in colorectal and lung cancer?Kathryn A. Martinez, Claire Frances Snyder, Jennifer Malin, Sydney M. Dy
Journal of Pain and Symptom Management. 2014-12-01 - 79 citationsSymptom Prevalence in Lung and Colorectal Cancer PatientsAnne Walling, Jane C. Weeks, Katherine L. Kahn, Diana M. Tisnado, Nancy L. Keating
Journal of Pain and Symptom Management. 2015-02-01 - 296 citationsEnd-of-life care discussions among patients with advanced cancer: a cohort study.Jennifer W. Mack, Angel M. Cronin, Nathan Taback, Haiden A. Huskamp, Nancy L. Keating
Annals of Internal Medicine. 2012-02-07
Press Mentions
- The 16th Annual Personalized Medicine Conference at Harvard Medical School: FROM AN ENTERPRISE TO AN ERA – How the Emergence of COVID-19 Effects Personalized Medicine, November 17 – 18, 2021 • Harvard Medical School, Boston, MAMarch 7th, 2021
NCCN: Costly Innovative Cancer Therapies Pose New Challenges—Financial and OtherwiseMarch 22nd, 2019
NCCN 2019 Annual Conference Includes Focus on Patient Experience with Innovative Therapies, plus Updates on Biomarkers, Biosimilars, and the Latest Research on Cancer CareMarch 4th, 2019
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
